SIMLUKAFUSP ALFA: 54 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
54
Total FAERS Reports
12 (22.2%)
Deaths Reported
41
Hospitalizations
54
As Primary/Secondary Suspect
5
Life-Threatening
2
Disabilities
First Report: 20180312 · Latest Report: 20220117
What Are the Most Common SIMLUKAFUSP ALFA Side Effects?
#1 Most Reported
Drug-induced liver injury
5 reports (9.3%)
#2 Most Reported
Acute kidney injury
4 reports (7.4%)
#3 Most Reported
Lymphopenia
3 reports (5.6%)
All SIMLUKAFUSP ALFA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug-induced liver injury | 5 | 9.3% | 2 | 3 |
Who Reports SIMLUKAFUSP ALFA Side Effects? Age & Gender Data
Gender: 36.8% female, 63.2% male. Average age: 61.1 years. Most reports from: ES. View detailed demographics →
Is SIMLUKAFUSP ALFA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 15 | 1 | 12 |
| 2019 | 28 | 5 | 19 |
| 2020 | 10 | 6 | 9 |
| 2022 | 1 | 0 | 1 |
What Is SIMLUKAFUSP ALFA Used For?
| Indication | Reports |
|---|---|
| Neoplasm | 12 |
| Metastatic neoplasm | 11 |
| Non-small cell lung cancer | 7 |
| Renal cell carcinoma | 7 |
| Oesophageal squamous cell carcinoma | 5 |
Official FDA Label for SIMLUKAFUSP ALFA
Official prescribing information from the FDA-approved drug label.